Ultrapar CFO granted 25,798 restricted shares

Palhares Alexandre Mendes reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Palhares Alexandre Mendes reported acquisition or exercise transactions in this Form 4 filing.

ULTRAPAR HOLDINGS INC reported that CFO and IRO Alexandre Mendes Palhares received a grant of 25,798 Restricted Shares on April 24, 2026. Each restricted share represents a contingent right to receive one common share and will vest over time until April 24, 2029.

After this compensation award, Palhares directly holds 259,234 common shares-equivalent, reflecting his updated equity position in the company.

Insider Trade Summary

Grant/Award: 25,798 shares

Grant/Award 1 txn

Insider Palhares Alexandre Mendes

Role CFO and IRO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Shares	25,798	$0.00	$0.00

Holdings After Transaction: Restricted Shares — 259,234 contracts (Direct)

Footnotes (2)

F1. Each restricted share represents a contingent right to receive one common share.
F2. Restricted shares that vest until April 24, 2029.

Key Figures

Restricted Shares granted: 25,798 shares Total shares after transaction: 259,234 shares Grant price per share: $0.00 per share +2 more

5 metrics

Restricted Shares granted 25,798 shares Grant to CFO on April 24, 2026

Total shares after transaction 259,234 shares Direct holdings of CFO following grant

Grant price per share $0.00 per share Equity compensation award, not open-market purchase

Underlying common shares 25,798 shares Each Restricted Share equals one common share

Vesting end date April 24, 2029 Restricted Shares vest until this date

Key Terms

Restricted Shares, contingent right, vest, grant, award, or other acquisition

4 terms

Restricted Shares financial

"Each restricted share represents a contingent right to receive one common share."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

contingent right financial

"Each restricted share represents a contingent right to receive one common share."

vest financial

"Restricted shares that vest until April 24, 2029."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did UGP disclose for CFO Alexandre Mendes Palhares?

Ultrapar Holdings (UGP) disclosed that CFO and IRO Alexandre Mendes Palhares received a grant of 25,798 Restricted Shares. These are compensation-related awards, not open-market purchases, and each represents a right to receive one common share upon vesting.

How many shares did the Ultrapar (UGP) CFO hold after the latest Form 4?

Following the April 24, 2026 grant, Ultrapar CFO Alexandre Mendes Palhares directly held 259,234 shares. This figure includes the newly awarded 25,798 Restricted Shares, which convert to common shares as they vest under the company’s equity compensation plan.

What are the terms of the Restricted Shares granted to Ultrapar (UGP) CFO?

Each Restricted Share granted to Ultrapar’s CFO represents a contingent right to receive one common share. According to the disclosure, these Restricted Shares vest over a period that runs until April 24, 2029, tying the award to multi-year service and performance.

Is the UGP Form 4 transaction a stock purchase or a compensation award?

The UGP Form 4 reports a compensation award, not a market purchase. The 25,798 shares were received under transaction code “A,” indicating a grant or award, with a price per share of $0.00, typical for equity-based compensation from the issuer.

Do the Restricted Shares for Ultrapar (UGP) CFO have an exercise price or expiration?

The reported Restricted Shares have no exercise price; they simply convert into common shares upon vesting. Footnotes state they vest until April 24, 2029, and each represents one common share, making them time-based stock awards rather than stock options.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/28/2026 - 01:39 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Palhares Alexandre Mendes

(Last)

(First)

(Middle)

BRIGADEIRO LUIS ANTONIO AVENUE, 1343

9TH FLOOR

(Street)

SAO PAULO

01317 910

(City)

(State)

(Zip)

BRAZIL

(Country)

2. Issuer Name and Ticker or Trading Symbol
ULTRAPAR HOLDINGS INC [ UGP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CFO and IRO

2a. Foreign Trading Symbol
[UGPA3]

3. Date of Earliest Transaction (Month/Day/Year)
04/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Shares	⁽¹⁾	04/24/2026		A		25,798		⁽²⁾	⁽²⁾	Common Shares	25,798	$0	259,234	D

Explanation of Responses:

1. Each restricted share represents a contingent right to receive one common share.

2. Restricted shares that vest until April 24, 2029.

	/s/ Larissa Lordaro Pessoa, attorney-in-fact for	04/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR